公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1990 | Metabolic Effects of Suramin(S) on Human Prostatic Cancer Cells | Rago, R.; Mitchen, J.; Cheng, Ann-Lii; 鄭安理 | Annual Meeting of the American Association for Cancer Research. Proceedings | | | |
1994 | Modulation of Retinoic Acid Receptor α, Growth Factors, and Protooncogenes in Retinoic Acid-Induced Apoptosis of Ki-1 Lymphoma Cell Line | Cheng, Ann-Lii; Chang, I. C.; Su, I. J.; Lay, A. D.; 鄭安理 | International Journal of Oncology | | | |
2012 | Novel sorafenib derivatives (SC-40, SC-43 and SC-60) show better anti-tumor effects than sorafenib in hepatocellular carcinoma through SHP-1/STAT3-mediated signaling pathway | Tai, Wei-Tien; Shiau, Chung-Wai; Cheng, Ann-Lii; Chen, Pel-Jer; Chen, Kuen-Feng; 陳培哲 | Cancer Res. | 0 | 0 | |
2014 | Nuclear expression of BCL10 has a role in the regulation of cell growth and progression of pancreatic cancer through the activation of NF-kappa B-related signaling | Kuo, Sung-Hsin; Yang, Shih-Hung; Yeh, Kun-Huei; Yeh, Pei-Yen; Tien, Yu-Wen; Lee, Hsiao-Wei; Chen, Li-Tzong; Cheng, Ann-Lii; 鄭安理 | Cancer Res. | 0 | 0 | |
2013 | Nuclear Expression of Glioma-Associated Oncogene Homo log 1 and Nuclear Factor-kappa B Is Associated with a Poor Prognosis of Pancreatic Cancer | Yang, Shih-Hung; Hsu, Chih-Hung; Lee, Jen-Chieh; Tien, Yu-Wen; Kuo, Sung-Hsin; Cheng, Ann-Lii | Oncology | | | |
2001 | Nuclear Extracellular Signal-Regulated Kinase 2 Phosphorylates P53 at Thr 55 in Response to Doxorubicin | CHENG, ANN-LII; 鄭安理 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | | | |
2011 | Optimization of Culture Condition for ACEI and GABA Production by Lactic Acid Bacteria | Tung, YT; Ou, Da-Liang; TZU-MING PAN ; Tung, Yi-Ting; Chang, Chun-Jung; Lee, BH; Lee, Bao-Hong; Liu, CF; Jeng, Yung-Ming; Liu, Chin-Feng; Lin, Yi-Jang; Pan, Tzu-Ming ; Pan, TM.; Lin, Zhong-Zhe; Gandhi, Anita K.; Liao, Sheng-Chieh; Huang, Zi-Ming; Hsu, Chiun; Cheng, Ann-Lii; 鄭永銘; 張純榮; 林宗哲; 鄭安理; 許駿; 歐大諒 | Journal of Food Science | 32 | 26 | |
2018 | Organ-specific differential responses to immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma | Lu, Li-Chun; Hsu, Chiun; Shao, Yu-Yun; Chao, Yee; Yen, Chia-Jui; Shih, I.-Lun; Hung, Yi-Ping; Chang, Chun-Jung; Shen, Ying-Chun; Guo, Jhe-Cyuan; Liu, Tsung-hao; Hsu, Chih-Hung; Cheng, Ann-Lii; YI-PING HUNG | Cancer Research | 0 | 1 | |
2013 | Oxidative stress enhances Axl-mediated cell migration through an Aktl/Racl-dependent mechanism | Huang, Jhy-Shrian; Cho, Chun-Yu; Hong, Chih-Chen; Yan, Ming-De; Hsieh, Mao-Chih; Lay, Jong-Ding; Lai, Gi-Ming; Cheng, Ann-Lii; Chuang, Shuang-En | Free Radic. Biol. Med. | | | |
1992 | Peripheral T-Cell Lymphoma and Adult T-Cell Lymphoma/Leukemia | Cheng, Ann-Lii; 鄭安理 | Current Therapy for Hematology/Oncology | | | |
2006 | PHASE I STUDY OF BIWEEKLY GEMCITABINE FOLLOWED BY OXALIPLATIN AND SIMPLIFIED 48-H INFUSION OF FLUOROURACIL/LEUCOVORIN FOR ADVANCED PANCREATIC CANCER | CHANG, HUI-JU; WANG, CHUAN-CHENG; CHENG, ANN-LII; 張俊彥 | J GASTROENTEROL HEPATOL | | | |
2006 | Phase I-Ii Trial of Weekly Gemcitabine Plus High-Dose 5-Fluorouracil and Leucovorin in Advanced Pancreatic Cancer | CHENG, ANN-LII; HSU, CHIUN; HSU, CHIH-HUNG; 鄭安理 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | | | |
2005 | A Phase Ii Study in Taiwan with Navelbine(Nvb) Oral in Combinatino with Cisplatin (C) in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients | YU, CHONG-JEN; YANG, CHIH-HSIN; CHENG, ANN-LII; YANG, PAN-CHYR; 鄭安理; 楊泮池 | LUNG CANCER | | | |
2009 | Phase Ii Study of Cetuximab Plus Weekly Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin for the First-Line Treatment of Advanced Gastric Cancer | YEH, KUN-HUEI; HSU, CHIH-HUNG; HSU, CHIUN; LIN, CHING-HUNG; SHEN, YING-CHUN; CHIOU, TZEON-JYE; CHAO, YEE; CHENG, ANN-LII | JOURNAL OF CLINICAL ONCOLOGY | | | |
2009 | A Phase Ii Study of Gemcitabine-Based Chemoradiotherapy (Ccrt) after Triplet Induction Chemotherapy (Ict) for Locally Advanced Pancreatic Cancer (Lapc): A Taiwan Cooperative Oncology Group (Tcog) Study | CHENG, ANN-LII; CHEN, LI-TZONG; 鄭安理 | JOURNAL OF CLINICAL ONCOLOGY | | | |
2002 | Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma | CHIUN HSU ; Huang, Chiun-Sheng; Chao, Tsu-Yi; Lu, Yen-Shen; Bu, Ching-Fang; Chen, Mary M; Chang, King-Jeng; Cheng, Ann-Lii | Cancer | 12 | 11 | |
2007 | Phase Ii Trial of the Efficacy and Safety of Sunitinib Malate Monotherapy in Unresectable Hepatocellular Carcinoma | CHENG, ANN-LII; 鄭安理 | ANNALS OF ONCOLOGY | | | |
2015 | Postchemoradiotherapy (CRT) pathologic stage classified by American Joint Committee on Cancer (AJCC) staging system to predict prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC) | Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Journal of Clinical Oncology | 0 | 0 | |
2013 | Potential synergistic antitumor activity between sorafenib and lenalidomide in an orthotopic murine liver cancer model. | Chang, Chun-Jung; Ou, Da-Liang; Lin, Yi-Jang; Cheng, Ann-Lii; Hsu, Chiun; 鄭安理 | Cancer Res. | 0 | 0 | |
2013 | Prevalence of gene amplifications of SOX-2, c-MET, and FGFR1 in Asian patients with esophageal squamous cell carcinoma. | Huang, Ta-Chen; Chen, Wei-Wu; Hsu, Ta-Wen; Lin, Chia-Chi J.; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | J. Clin. Oncol. | | | |